A study to describe the characteristics, health care interventions and outcomes of patients with major bleedings in the presence of Factor Xa inhibitor treatment

Trial Identifier: D9603R00003
Sponsor: AstraZeneca
Collaborator:
Parexel
NCTID:: NCT06147830
Start Date: December 2023
Primary Completion Date: March 2025
Study Completion Date: March 2025

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Germany Aachen, Germany
Germany Altenburg, Germany
Germany Bad Neustadt/Saale, Germany
Germany Berlin, Germany
Germany Bochum, Germany
Germany Bonn, Germany
Germany Dortmund, Germany
Germany Dresden, Germany
Germany Göttingen, Germany
Germany Halle, Germany
Germany Jena, Germany
Germany Koblenz, Germany
Germany Köln, Germany
Germany Leipzig, Germany
Germany Lübeck, Germany
Germany Ludwigshafen am Rhein, Germany
Germany Lüneburg, Germany
Germany Osnabrück, Germany
Germany Potsdam, Germany
Germany Saarbrücken, Germany
Germany Trier, Germany
Germany Tuebingen, Germany
Germany Wurzburg, Germany
Japan Asahikawa, Japan
Japan Fukuoka, Japan
Japan Hitachi, Japan
Japan Izumo, Japan
Japan Kagoshima, Japan
Japan Kamakura, Japan
Japan Kitakyushu, Japan
Japan Kyoto, Japan
Japan Mitaka, Japan
Japan Nagakute, Japan
Japan Saga, Japan
Japan Shimotsuke, Japan
Japan Suita, Japan
Japan Tachikawa, Japan
Japan Tokyo, Japan
United Kingdom Aberdeen, United Kingdom
United Kingdom Bournemouth, United Kingdom
United Kingdom Canterbury, United Kingdom
United Kingdom Cardiff, United Kingdom
United Kingdom Edgbaston, United Kingdom
United Kingdom Harrow, United Kingdom
United Kingdom Liverpool, United Kingdom
United Kingdom London, United Kingdom
United Kingdom Oxford, United Kingdom
United Kingdom Preston, United Kingdom
United Kingdom Sheffield, United Kingdom
United Kingdom Southampton, United Kingdom
USA, California Orange, California, USA, 92868
USA, California Torrance, California, USA, 90509
USA, Illinois Glenview, Illinois, USA, 60026
USA, Kansas Kansas City, Kansas, USA, 66160
USA, Kentucky Lexington, Kentucky, USA, 40536
USA, Michigan Royal Oak, Michigan, USA, 48073
USA, Missouri Saint Louis, Missouri, USA, 63110
USA, New York New Hyde Park, New York, USA, 11040
USA, New York Staten Island, New York, USA, 10305
USA, New York Stony Brook, New York, USA, 11794
USA, Ohio Columbus, Ohio, USA, 43210
USA, Ohio Toledo, Ohio, USA, 43614
USA, Texas Dallas, Texas, USA, 75390